| Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma K Kushitani, Y Takeshima, VJ Amatya, O Furonaka, A Sakatani, K Inai Pathology international 57 (4), 190-199, 2007 | 130 | 2007 |
| The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma Y Tsutani, Y Miyata, T Mimae, K Kushitani, Y Takeshima, M Yoshimura, ... The Journal of thoracic and cardiovascular surgery 146 (3), 580-585, 2013 | 95 | 2013 |
| Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma Y Takeshima, VJ Amatya, K Kushitani, M Kaneko, K Inai Histopathology 54 (6), 667-676, 2009 | 83 | 2009 |
| Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry K Kushitani, Y Takeshima, VJ Amatya, O Furonaka, A Sakatani, K Inai Pathology international 58 (2), 75-83, 2008 | 83 | 2008 |
| A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases Y Takeshima, VJ Amatya, K Kushitani, K Inai American journal of clinical pathology 130 (5), 771-779, 2008 | 66 | 2008 |
| Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma H Kohno, VJ Amatya, Y Takeshima, K Kushitani, N Hattori, N Kohno, ... Oncology reports 24 (2), 423-431, 2010 | 60 | 2010 |
| miR-182 and miR-183 promote cell proliferation and invasion by targeting FOXO1 in mesothelioma R Suzuki, VJ Amatya, K Kushitani, Y Kai, T Kambara, Y Takeshima Frontiers in oncology 8, 446, 2018 | 53 | 2018 |
| Prognostic role of subtype classification in small-sized pathologic N0 invasive lung adenocarcinoma T Yoshiya, T Mimae, Y Tsutani, N Tsubokawa, S Sasada, Y Miyata, ... The Annals of Thoracic Surgery 102 (5), 1668-1673, 2016 | 51 | 2016 |
| Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications M Ito, Y Miyata, K Kushitani, T Yoshiya, T Mimae, Y Ibuki, K Misumi, ... Lung Cancer 85 (2), 270-275, 2014 | 43 | 2014 |
| Aberrant methylation and loss of expression of O6‐methylguanine‐DNA methyltransferase in pulmonary squamous cell carcinoma and adenocarcinoma O Furonaka, Y Takeshima, H Awaya, K Kushitani, N Kohno, K Inai Pathology international 55 (6), 303-309, 2005 | 42 | 2005 |
| Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer Y Tsutani, Y Miyata, K Kushitani, Y Takeshima, M Yoshimura, M Okada The Journal of Thoracic and Cardiovascular Surgery 148 (4), 1179-1185, 2014 | 37 | 2014 |
| Caveolin‐1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma VJ Amatya, Y Takeshima, H Kohno, K Kushitani, T Yamada, C Morimoto, ... Histopathology 55 (1), 10-19, 2009 | 36 | 2009 |
| Segmentectomy vs lobectomy for clinical stage IA lung adenocarcinoma with spread through air spaces A Kagimoto, Y Tsutani, K Kushitani, Y Kai, T Kambara, Y Miyata, ... The Annals of Thoracic Surgery 112 (3), 935-943, 2021 | 35 | 2021 |
| Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma K Kushitani, VJ Amatya, Y Okada, Y Katayama, AS Mawas, Y Miyata, ... Histopathology 70 (3), 375-384, 2017 | 35 | 2017 |
| Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma VJ Amatya, AS Mawas, K Kushitani, MM Mohi El-Din, Y Takeshima International journal of oncology 48 (4), 1599-1607, 2016 | 35 | 2016 |
| Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines VJ Amatya, Y Takeshima, K Kushitani, T Yamada, C Morimoto, K Inai Oncology reports 26 (6), 1369-1375, 2011 | 35 | 2011 |
| MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung AS Mawas, VJ Amatya, K Kushitani, Y Kai, Y Miyata, M Okada, ... Scientific Reports 8 (1), 134, 2018 | 33 | 2018 |
| Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma T Mimae, Y Tsutani, Y Miyata, T Yoshiya, Y Ibuki, K Kushitani, ... The Journal of Thoracic and Cardiovascular Surgery 147 (6), 1820-1826, 2014 | 33 | 2014 |
| MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma VJ Amatya, K Kushitani, AS Mawas, Y Miyata, M Okada, T Kishimoto, ... Modern Pathology 30 (5), 672-681, 2017 | 31 | 2017 |
| Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report Y Hamai, J Hihara, M Emi, Y Aoki, K Kushitani, K Tanabe, M Okada BMC gastroenterology 12, 1-7, 2012 | 26 | 2012 |
